Hati Health welcomes Singapore Diagnostics to its network, giving Filipinos access to world-class diagnostics, from routine labs to genetic testing, nationwide
July 15, 2026 • 5 MIN READ
MANILA, PHILIPPINES — JULY 15, 2026 — Hati Health, the Philippines’ fastest-growing digital health marketplace, connecting Filipino families to diagnostics, consultations, vaccines, pharmacy, and corporate wellness services across 160+ partner locations nationwide, has expanded its network with the addition of Singapore Diagnostics (SGD). The partnership brings SGD’s full range of laboratory services, from everyday blood panels to advanced genetic testing, onto the Hati Health platform, alongside SGD’s home service laboratory, making internationally accredited diagnostics more accessible to Filipinos wherever they are.
A major addition to the Hati Health Provider Network
SGD is one of the most significant partners to join the Hati Health network to date. As the Philippine subsidiary of Singapore-based Pathology Asia Holdings and an institution accredited by the College of American Pathologists (CAP) — the global gold standard in laboratory medicine — SGD brings a level of scientific rigor and diagnostic reliability that places it firmly among the world's most advanced laboratories.
From routine blood work to complex genetic panels, oncology diagnostics, and clinical trials commissioned by global pharmaceutical companies, SGD's results consistently meet the same benchmarks as leading laboratories in the U.S. and Europe.
“At Singapore Diagnostics, our mission has always been to make world-class, affordable laboratory testing accessible to more Filipinos. Partnering with Hati Health allows us to reach more communities and make preventive healthcare simpler, more connected, and within everyone's reach” says Ritche Evidente, President and CEO of Singapore Diagnostics.
"Every partnership we add to the Hati Health network brings us closer to our goal: a Philippines where every family, regardless of where they live, can find trusted healthcare at a price they can see upfront. SGD is a landmark addition to that network. Their reach, their standards, and their commitment to every Filipino patient align completely with what we are building," said Maria Gaitanidou, CEO & Co-Founder of Hati Health.
Diagnostics, delivered—including at your door
One of the most significant features of this partnership is the integration of SGD's Home Service Laboratory into the Hati Health platform. Through SGD's mobile phlebotomy service, patients can now schedule a licensed professional to collect samples at home, with specimens delivered directly to SGD labs for processing. No hospital visit. No queue. No uncertainty.
Through Hati Health, patients across Luzon, Iloilo, Bacolod, and Cebu can now:
- Book diagnostic tests across SGD’s growing network of 22 locations: easily searchable by area, with transparent pricing displayed upfront before booking.
- Schedule home sample collection: have a licensed phlebotomist come to you, on your schedule.
- Access CAP-accredited results: from routine panels and basic labs to complex genetic testing and oncology diagnostics, with the confidence of internationally benchmarked standards.
Building a Provider Network Filipinos can trust
This partnership is part of Hati Health's broader mission to build the Philippines' most trusted and comprehensive digital health network, connecting patients not just to convenience, but to quality. SGD's track record with global pharmaceutical companies, and leading medical institutions annually makes it a cornerstone addition to that network.
With every new partner, Hati Health brings Filipinos closer to a healthcare experience defined by transparency, reliability, and ease, wherever they are in the country.
About Singapore Diagnostics (SGD)
Singapore Diagnostics (SGD) is the Philippine subsidiary of Pathology Asia Holdings, headquartered in Singapore. Accredited by the College of American Pathologists (CAP) — the global gold standard in laboratory medicine — SGD operates a network of 70 full-service laboratories nationwide and has served 2.5M patients in 2025. SGD’s menu spans routine blood work and wellness panels, advanced genetic testing, oncology diagnostics, and clinical trials commissioned by global pharmaceutical companies. Through its home service laboratory, SGD deploys licensed phlebotomists directly to patients’ homes, with specimens processed at its CAP-accredited facilities. SGD serves over two and a half million patients annually.
About Hati Health
Hati Health is the Philippines’ fastest-growing digital health marketplace, connecting Filipino families to diagnostics, consultations, vaccines, pharmacy services, home health kits, and corporate wellness programs across 160+ partner clinics and laboratories nationwide. With transparent upfront pricing, seamless online and in-app booking, HMO integration, and a mobile app launched in June 2025, Hati Health makes it easier for Filipinos to access the care they need — when and where they need it. Visit www.hati.health to learn more.
